BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,710 | -17.4% | 98,301 | -0.3% | 0.02% | -17.2% |
| Q2 2023 | $4,490 | +22.7% | 98,550 | +9.3% | 0.03% | +11.5% |
| Q1 2023 | $3,658 | -18.5% | 90,186 | +2.4% | 0.03% | -23.5% |
| Q4 2022 | $4,487 | -99.9% | 88,041 | -2.9% | 0.03% | -10.5% |
| Q3 2022 | $4,881,000 | -19.3% | 90,626 | -3.8% | 0.04% | -15.6% |
| Q2 2022 | $6,052,000 | -49.2% | 94,220 | -38.6% | 0.04% | -35.7% |
| Q1 2022 | $11,906,000 | +25.8% | 153,549 | +40.2% | 0.07% | +42.9% |
| Q4 2021 | $9,467,000 | +12.4% | 109,513 | +4.6% | 0.05% | +6.5% |
| Q3 2021 | $8,422,000 | +0.4% | 104,716 | +0.5% | 0.05% | -11.5% |
| Q2 2021 | $8,391,000 | -8.5% | 104,233 | -4.2% | 0.05% | -13.3% |
| Q1 2021 | $9,175,000 | +6.7% | 108,784 | +1.5% | 0.06% | +1.7% |
| Q4 2020 | $8,601,000 | +0.6% | 107,187 | +0.8% | 0.06% | -4.8% |
| Q3 2020 | $8,550,000 | -44.9% | 106,322 | -41.0% | 0.06% | -50.8% |
| Q2 2020 | $15,526,000 | -62.7% | 180,330 | -64.8% | 0.13% | -41.7% |
| Q1 2020 | $41,616,000 | -36.3% | 512,574 | -34.4% | 0.22% | -58.0% |
| Q4 2019 | $65,379,000 | -21.8% | 781,855 | -18.2% | 0.51% | -27.2% |
| Q3 2019 | $83,568,000 | +76.9% | 955,391 | +65.7% | 0.71% | +73.5% |
| Q2 2019 | $47,230,000 | +18.4% | 576,673 | +17.6% | 0.41% | +11.8% |
| Q1 2019 | $39,880,000 | -17.5% | 490,467 | -33.2% | 0.36% | -15.9% |
| Q4 2018 | $48,331,000 | -32.0% | 734,293 | -20.4% | 0.43% | -19.8% |
| Q3 2018 | $71,087,000 | +3.3% | 922,132 | -1.1% | 0.54% | -8.2% |
| Q2 2018 | $68,843,000 | +42.4% | 932,332 | +25.4% | 0.59% | +26.2% |
| Q1 2018 | $48,346,000 | -18.4% | 743,320 | -18.9% | 0.47% | -8.4% |
| Q4 2017 | $59,223,000 | +20.1% | 916,205 | +16.6% | 0.51% | +13.9% |
| Q3 2017 | $49,309,000 | +59.8% | 785,795 | +54.2% | 0.45% | +50.5% |
| Q2 2017 | $30,855,000 | +36.0% | 509,671 | +16.5% | 0.30% | +177.6% |
| Q1 2017 | $22,688,000 | +52.8% | 437,480 | +40.2% | 0.11% | -33.5% |
| Q3 2016 | $14,849,000 | +6.4% | 311,952 | +1.1% | 0.16% | +3.2% |
| Q2 2016 | $13,960,000 | +8.8% | 308,692 | -1.2% | 0.16% | +8.3% |
| Q1 2016 | $12,829,000 | – | 312,293 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |